Skip to main content
. 2014 Sep 26;5(21):10692–10708. doi: 10.18632/oncotarget.2530

Figure 2. hUCESCs-CM reduced cell proliferation in MDA-MB-231 cells but not in the MCF-7 cells.

Figure 2

(A-B): MTT assay of MCF-7 cells treated for 24 and 48 hours with complete medium (+FBS), incomplete medium (−FBS), 24 and 48-hour MCF-7-CM, and 24 and 48-hour hUCESCs-CM. (C-D): MTT assay of MDA-MB-231 cells treated as above. ns: not significant.